Document Detail

Subcutaneous Immunoglobulin Replacement Therapy with Hizentra® is Safe and Effective in Two Infants.
MedLine Citation:
PMID:  22228569     Owner:  NLM     Status:  Publisher    
Hizentra® is a 20% liquid IgG product approved for subcutaneous administration in adults and children greater than 2 years of age. We report two infants less than 2 years in which administration of Hizentra® was safe and effective.
Joel L Gallagher; Niraj C Patel
Related Documents :
10772519 - Electrical burn of urethra as cause of stricture after transurethral resection.
25218939 - Treatment and prevention of hip dysplasia in infants and young children.
23143319 - The death of robert falcon scott (1869-1912) and colleagues.
25394569 - Congenital talipes equinovarus: frequency of associated malformations not identified by...
16736059 - Real-time and time-integrated pm2.5 and co from prescribed burns in chipped and non-chi...
25452889 - Life-threatening qt prolongation in a preterm infant.
6626059 - Nutrition in the first year of life in a multi-ethnic poor socio-economic municipality ...
715829 - Two determinants of fertility decline: a test of competing models.
10794789 - Thyroid function in very low birthweight infants after intravenous administration of th...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-1-8
Journal Detail:
Title:  Journal of clinical immunology     Volume:  -     ISSN:  1573-2592     ISO Abbreviation:  -     Publication Date:  2012 Jan 
Date Detail:
Created Date:  2012-1-9     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8102137     Medline TA:  J Clin Immunol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Department of Pediatrics, Carolinas Medical Center, Levine Children's Hospital, P.O. Box 32861, Charlotte, NC, 28232, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Immune-Mediated Diseases and Immunodeficiencies Associated with Thymic Epithelial Neoplasms.
Next Document:  Cytokine Production Is Altered in Monocytes from Children with Hemolytic Uremic Syndrome.